Home Newsfeeds Pfizer Study Shows Bivalent Boosters Offer No Short-Term Superiority

Pfizer Study Shows Bivalent Boosters Offer No Short-Term Superiority

-Reuters

byBenzinga Newsdesk

October 25, 2022

1 minute read

-Reuters

Coinbase-Incubated Base Faces Major Outage, Assures ‘No Funds Are At Risk’

By Benzinga Neuro

September 6, 1:01 AM

Coinbase Global Inc (NASDAQ:COIN)-backed Ethereum (CRYPTO: ETH) Layer-2 network, Base, experienced a significant outage on Tuesday, taking an hour to fully rectify.

COIN

Verastem Oncology Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants; No Terms Disclosed

By Benzinga Newsdesk

June 15, 4:00 PM

Verastem Oncology, (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and pre-funded

VSTM

Impinj Q4 Adj. EPS $0.41 Beats $0.40 Estimate, Sales $76.60M Beat $75.15M Estimate

By Bill Haddad

February 8, 5:20 PM

Impinj (NASDAQ:PI) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.40 by 2.5 percent. This is a 156.25 percent increase over earnings of $0.16 per share from the same period

Bitcoin, Ethereum Move Higher Following Jobs Data; Arweave Emerges As Top Gainer

By Avi Kapoor

May 3, 9:42 AM

Bitcoin (CRYPTO: BTC) moved higher, with the cryptocurrency prices trading above the key $59,000 level on Friday. Ethereum (CRYPTO: ETH) also edged higher, but remained below the key $3,000 mark this morning.

$GNO

Pfizer Study Shows Bivalent Boosters Offer No Short-Term Superiority

Related Posts

Coinbase-Incubated Base Faces Major Outage, Assures ‘No Funds Are At Risk’

Verastem Oncology Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants; No Terms Disclosed

Impinj Q4 Adj. EPS $0.41 Beats $0.40 Estimate, Sales $76.60M Beat $75.15M Estimate

Bitcoin, Ethereum Move Higher Following Jobs Data; Arweave Emerges As Top Gainer